MedTrace Logo

Study of Low-level Laser Therapy in the Acute Treatment of Migraine

NCT02969642 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-12-02

No results posted yet for this study

Summary

This study evaluates the treatment of migraine pain using low energy laser light to quench migraine signals issuing from the sphenopalatine ganglion (SPG).

Conditions

  • Migraine Headache

Interventions

DEVICE

Argus Migraine Treatment device

treatment of Migraines targeting Sphenopalatine ganglion

Sponsors & Collaborators

  • The San Francisco Clinical Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-05-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969642 on ClinicalTrials.gov